Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics March 30, 2021
PTC Therapeutics Announces the European Approval of Evrysdi™ for the Treatment of Spinal Muscular Atrophy March 30, 2021
Lassen Therapeutics Announces Collaboration with Cedars Sinai Medical Center to Study the Role of IL-11 Signaling and Inhibition in Preclinical Models of Lung Fibrosis March 25, 2021
XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease March 25, 2021
Pfizer ships out 2 cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO March 25, 2021
